β-Catenin/TCF-4 signaling regulates susceptibility of macrophages and resistance of monocytes to HIV-1 productive infection

Current HIV Research

Volumn 12, Issue 3, 2014, Pages 164-173

  Aljawai, Yosra ^a   Richards, Maureen H ^a   Seaton, Melanie S ^a   Narasipura, Srinivas D ^a   Al Harthi, Lena ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

HIV; Macrophages; Monocytes; NeuroAIDS; Viral pathogenesis; Catenin signaling

Indexed keywords

BETA CATENIN; GREEN FLUORESCENT PROTEIN; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; TCF4 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DOWN REGULATION; ELECTROPORATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETIC ANALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LUCIFERASE ASSAY; MACROPHAGE; MONOCYTE; NONHUMAN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; VIRUS REPLICATION; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; VIROLOGY;

BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BETA CATENIN; HIV-1; HUMANS; MACROPHAGES; MONOCYTES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; VIRUS REPLICATION;

EID: 84906227997     PISSN: 1570162X     EISSN: 18734251     Source Type: Journal    
DOI: 10.2174/1570162X12666140526122249     Document Type: Article

References (55)

1. Gallo RC, Salahuddin SZ, Popovic, et al. Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 1984; 224: 500-03
2. Popovic, M, Sarngadharan, MG, et al. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984; 224: 497-500
3. Gallo, RC, Sarin, et al. Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS). Science 1983; 220: 865-7
4. Barre Sinoussi, F Chermann, JC Rey, et al. Isolation of a Tlymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983; 220: 868-71
5. Alexaki, A Liu Y, Wigdahl B, et al. Cellular reservoirs of HIV-1 and their role in viral persistence. Curr HIV Res 2008; 6: 388-400
6. Fischer Smith, T Bell, C Croul, et al. Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studies. J Neurovirol 2008; 14: 318-26
7. Mosser, DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958-69
8. Coma, G. Pena, R. Blanco. Treatment of monocytes with interleukin (IL)-12 plus IL-18 stimulates survival, differentiation and the production of CXC chemokine ligands (CXCL)8, CXCL9 and CXCL10. Clin Exp Immunol 2006; 45: 535-44
9. Darwich, L Coma, G Pena. Secretion of interferon-gamma by human macrophages demonstrated at the single-cell level after costimulation with interleukin (IL)-12 plus IL-18. Immunology 2009; 126: 386-93
10. Bergamaschi A, Pancino G. Host hindrance to HIV-1 replication in monocytes and macrophages. Retrovirology 2010; 7: 31
11. Cassol E Alfano, M Biswas P, Poli G. Monocyte-derived macrophages and myeloid cell lines as targets of HIV-1 replication and persistence. J Leukoc Biol 2006; 80: 1018-30
12. Kedzierska K, Crowe SM. The role of monocytes and macrophages in the pathogenesis of HIV-1 infection. Curr Med Chem 2002; 9: 1893-1903
13. Rich EA, Chen IS, Zack JA, et al. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J Clin Invest 1992; 89: 176-183
14. Sonza S, Maerz A, Uren S, et al. Susceptibility of human monocytes to HIV type 1 infection in vitro is not dependent on their level of CD4 expression. AIDS Res Hum Retroviruses 1995; 11: 769-76
15. Tuttle DL, Harrison JK, Anders C, et al. Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1. J Virol 1998; 72: 4962-69
16. Dong C, Kwas C, Wu L. Transcriptional restriction of human immunodeficiency virus type 1 gene expression in undifferentiated primary monocytes. J Virol 2009; 83: 3518-27
17. Pion M, Granelli Piperno A, Mangeat B, et al. APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection. J Exp Med 2006; 203: 2887-93
18. Palmieri C, Trimboli F, Puca A, et al. Inhibition of HIV-1 replication in primary human monocytes by the IkappaBalphaS32/ 36A repressor of NF-kappaB. Retrovirology 2004; 1: 45.
19. Triques K, Stevenson M. Characterization of restrictions to human immunodeficiency virus type 1 infection of monocytes. J Virol 2004; 78: 5523-27
20. Neil S, Martin F, Ikeda Y, et al,. Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes. J Virol 2001; 75: 5448-56
21. Henderson AJ, Zou X, Calame KL. C/EBP proteins activate transcription from the human immunodeficiency virus type 1 long terminal repeat in macrophages/monocytes. J Virol 1995; 69: 5337- 44
22. Kaushik R, Zhu X, Stranska R, et al. A cellular restriction dictates the permissivity of nondividing monocytes/macrophages to lentivirus and gammaretrovirus infection. Cell Host Microbe 2009; 6: 68-80
23. Naif HM, Li S, Alali M, et al. CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection. J Virol 1998; 72: 830-36
24. Sung TL, Rice AP. miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1. PLoS Pathog 2009; 5: e1000263
25. Arfi V, Riviere, Jarrosson Wuilleme L, et al. Characterization of the early steps of infection of primary blood monocytes by human immunodeficiency virus type 1. J Virol 2008; 82: 6557-65
26. Michel N, Goffinet C, Ganter K, et al. Human cyclin T1 expression ameliorates a T-cell-specific transcriptional limitation for HIV in transgenic rats, but is not sufficient for a spreading infection of prototypic R5 HIV-1 strains ex vivo. Retrovirology 2009; 6: 2
27. Kumar A, Zloza A, Moon RT, et al. Active {beta}-catenin signaling is an inhibitory pathway of HIV replication in peripheral blood mononuclear cells. J Virol 2008; 82: 2813-20
28. Narasipura SD, Henderson LJ, Fu SW, et al. Role of beta-catenin and TCF/LEF family members in transcriptional activity of HIV in astrocytes. J Virol 2012; 86: 1911-21
29. Li W, Henderson LJ, Major EO. IFN-{gamma} Mediates Enhancement of HIV Replication in Astrocytes by Inducing an Antagonist of the {beta}-Catenin Pathway (DKK1) in a STAT 3- Dependent Manner. J Immunol 2011; 18: 6771-8
30. Henderson LJ, Narasipura SD, Adarichev V, et al. Identification of novel T cell factor 4 (TCF-4) binding sites on the HIV long terminal repeat which associate with TCF-4, beta-catenin, and SMAR1 to repress HIV transcription. J Virol 2012; 86: 9495-03
31. Moon RT, Brown JD, Torres M. WNTs modulate cell fate and behavior during vertebrate development. Trends Genet 1997; 13: 157-62
32. Miller JR, Moon RT. Signal transduction through beta-catenin and specification of cell fate during embryogenesis. Genes Dev 1996; 10: 2527-39
33. Al Harthi L. Interplay between Wnt/beta-catenin signaling and HIV: virologic and biologic consequences in the CNS. J Neuroimmune Pharmacol 2012; 7: 731-9
34. Xie D, Yin D, Tong X, et al. Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and betacatenin- TCF/Lef signaling pathways. Cancer Res 2004; 64: 1987- 96
35. Chung EJ, Hwang SG, Nguyen P, et al. Regulation of leukemic cell adhesion, proliferation, and survival by beta-catenin. Blood 2002; 100: 982-90
36. Korinek V, Barker N, Morin PJ, et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997; 275: 1784-7
37. Carroll Anzinger D, Al Harthi L. Gamma interferon primes productive human immunodeficiency virus infection in astrocytes. J Virol 2006; 80: 541-4
38. Wortman B, Darbinian N, Sawaya BE, et al. Evidence for regulation of long terminal repeat transcription by Wnt transcription factor TCF-4 in human astrocytic cells. J Virol 2002; 76: 11159-65
39. Salim A, Ratner L. Modulation of beta-catenin and E-cadherin interaction by Vpu increases human immunodeficiency virus type 1 particle release. J Virol 2008; 82: 3932-8
40. Mantovani A, Sica A, Sozzani S, et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 2004; 25: 677-86
41. Bergamaschi A, Pancino G. Host hindrance to HIV-1 replication in monocytes and macrophages. Retrovirology 7: 31
42. Laguette N, Sobhian B, Casartelli N, et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 2011; 474: 654-7
43. Baril M, Es Saad S, Chatel Chaix L, et al. Genome-wide RNAi screen reveals a new role of a WNT/CTNNB1 signaling pathway as negative regulator of virus-induced innate immune responses. PLoS Pathog 2013; 9: e1003416
44. Estrabaud E, Le Rouzic E, Lopez Verges S, et al. Regulated degradation of the HIV-1 Vpu protein through a betaTrCPindependent pathway limits the release of viral particles. PLoS Pathog 2007; 3: e104
45. Hoeflich KP, Luo J, Rubie EA, et al. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 2000; 406: 86-90
46. Harris RS, Hultquist JF, Evans DT. The restriction factors of human immunodeficiency virus. J Biol Chem 2012; 287: 40875-83
47. Fischer Smith T, Croul S, Adeniyi A, et al. Macrophage/microglial accumulation and proliferating cell nuclear antigen expression in the central nervous system in human immunodeficiency virus encephalopathy. Am J Pathol 2004; 164: 2089-99
48. Fischer Smith T, Croul S, Sverstiuk AE, et al. CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J Neurovirol 2001; 7: 528-41
49. Ancuta P, Liu KY, Misra V, et al. Transcriptional profiling reveals developmental relationship and distinct biological functions of CD16+ and CD16- monocyte subsets. BMC Genomics 2009; 10: 403
50. Martinez FO. The transcriptome of human monocyte subsets begins to emerge. J Biol 2009; 8: 99
51. Ellery PJ, Tippett E, Chiu YL, et al. The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J Immunol 2007; 178: 6581-89
52. Komuro I, Yokota Y, Yasuda S, et al. CSF-induced and HIV-1- mediated distinct regulation of Hck and C/EBPbeta represent a heterogeneous susceptibility of monocyte-derived macrophages to M-tropic HIV-1 infection. J Exp Med 2003; 198: 443-53
53. Shen R, Richter HE, Clements RH, et al. Macrophages in vaginal but not intestinal mucosa are monocyte-like and permissive to human immunodeficiency virus type 1 infection. J Virol 2009; 83: 3258-67
54. Greenhead P, Hayes P, Watts PS, et al. Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J Virol 2000; 74: 5577-86
55. Nakata K, Weiden M, Harkin T, et al. Low copy number and limited variability of proviral DNA in alveolar macrophages from HIV-1-infected patients: evidence for genetic differences in HIV-1 between lung and blood macrophage populations. Mol Med 1995; 1: 744-57.